PPARGC1A and sarcopenia: Specifically, the age-related decline in SCFA-producing gut microbiomes leads to a reduction in SCFAs, through an AMPK-mediated regulatory pathway that modulates PGC-1α gene expression, affecting skeletal muscle protein metabolism and potentially contributing to sarcopenia.